Fig. 1From: The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseasesSputum culture results over time of each case. Halftone pattern indicates the period during inhaled AMK therapy. * indicates CLA-resistance (CLA MIC ≥32 [μg/mL]). “+” denotes positive sputum culture. “-” denotes negative sputum cultureBack to article page